Personalized medicine in cardiology: the time for genotype-guided therapy is now

被引：0
|
作者：
Cavallari, Larisa H. [1 ]
Nutescu, Edith A. [1 ]
Duarte, Julio D. [1 ]
机构：
[1] Univ Illinois, Dept Pharm Practice, 833 South Wood St,Room 164, Chicago, IL 60612 USA
来源：
FUTURE CARDIOLOGY | 2013年 / 9卷 / 04期
关键词：
genotype; personalized medicine; pharmacogenetics; polymorphism; warfarin;
D O I：
10.2217/FCA.13.35
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：459 / 464
页数：6
相关论文
共 50 条
  • [41] Genotype-guided therapy improves initial acenocoumarol dosing Results from a prospective randomised study
    Jose Cerezo-Manchado, Juan
    Roldan, Vanessa
    Corral, Javier
    Rosafalco, Mario
    Isabel Anton, Ana
    Padilla, Jose
    Vicente, Vicente
    Gonzalez-Conejero, Rocio
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (01) : 117 - 125
  • [42] Genotype-Guided P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention: A Bayesian Analysis
    Parcha, Vibhu
    Heindl, Brittain F.
    Li, Peng
    Kalra, Rajat
    Limdi, Nita A.
    Pereira, Naveen L.
    Arora, Garima
    Arora, Pankaj
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2021, 14 (06): : 731 - 739
  • [43] Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: Exploring the Role of Genotype-Guided Therapy in Reducing Readmission Rates
    Comanici, Maria
    Raja, Shahzad G.
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 203 : 507 - 508
  • [44] "Now Is a Time for Optimism": The Politics of Personalized Medicine in Mental Health Research
    Rueppel, Jonas
    SCIENCE TECHNOLOGY & HUMAN VALUES, 2019, 44 (04) : 581 - 611
  • [45] Genotype-guided dosing versus conventional dosing of warfarin: A meta-analysis of 15 randomized controlled trials
    Yang, Ting
    Zhou, Ying
    Chen, Chaoyang
    Lu, Min
    Ma, Lingyue
    Cui, Yimin
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (02) : 197 - 208
  • [46] Implementation of HLA-related genotype-guided prescribing in Singapore
    Chua, Hui Min
    Limenta, Michael
    Ng, Carol Yee Leng
    Lo, Elaine Ah Gi
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 82 (05) : e285 - e293
  • [47] A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy
    Henricks, Linda M.
    Lunenburg, Carin A. T. C.
    de Man, Femke M.
    Meulendijks, Didier
    Frederix, Geert W. J.
    Kienhuis, Emma
    Creemers, Geert-Jan
    Baars, Arnold
    Dezentje, Vincent O.
    Imholz, Alexander L. T.
    Jeurissen, Frank J. F.
    Portielje, Johanna E. A.
    Jansen, Rob L. H.
    Hamberg, Paul
    ten Tije, Albert J.
    Droogendijk, Helga J.
    Koopman, Miriam
    Nieboer, Peter
    van de Poel, Marlene H. W.
    Mandigers, Caroline M. P. W.
    Rosing, Hilde
    Beijnen, Jos H.
    van Werkhoven, Erik
    van Kuilenburg, Andre B. P.
    van Schaik, Ron H. N.
    Mathijssen, Ron H. J.
    Swen, Jesse J.
    Gelderblom, Hans
    Cats, Annemieke
    Guchelaar, Henk-Jan
    Schellens, Jan H. M.
    EUROPEAN JOURNAL OF CANCER, 2019, 107 : 60 - 67
  • [48] Meta-Analysis of Genotype-Guided Versus Standard Dosing of Vitamin K Antagonists
    Kheiri, Babikir
    Abdalla, Ahmed
    Haykal, Tarek
    Osman, Mohammed
    Ahmed, Sahar
    Hassan, Mustafa
    Bachuwa, Ghassan
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (07) : 879 - 887
  • [49] Genotype-Guided Vitamin K Antagonist Dosing Algorithms Improve Time in Therapeutic Range: A Systematic Review and Meta-Analysis
    BeIley-Cote, Emilie P.
    Hanif, Hasib
    D'Aragon, Frederick
    Eikelboom, John
    Anderson, Jeffrey L.
    Borgman, Mark
    Jonas, Daniel E.
    Kimmel, Stephen
    Maitland-van der Zee, Anke H.
    Pirmohamed, Munir
    Whitlock, Richard
    CIRCULATION, 2014, 130
  • [50] The next 10 years in personalized medicine in cardiology
    Tantry, Udaya S.
    Gurbel, Paul A.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (08) : 933 - 935
12345